Global VHH Nanobodies Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global VHH Nanobodies market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
This report is a detailed and comprehensive analysis for global VHH Nanobodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global VHH Nanobodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for VHH Nanobodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global VHH Nanobodies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
VHH Nanobodies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe VHH Nanobodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of VHH Nanobodies, with price, sales quantity, revenue, and global market share of VHH Nanobodies from 2020 to 2025.
Chapter 3, the VHH Nanobodies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the VHH Nanobodies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and VHH Nanobodies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of VHH Nanobodies.
Chapter 14 and 15, to describe VHH Nanobodies sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
This report is a detailed and comprehensive analysis for global VHH Nanobodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global VHH Nanobodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global VHH Nanobodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for VHH Nanobodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global VHH Nanobodies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
VHH Nanobodies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monovalent Nanobodies
- Bivalent Nanobodies
- Bispecific Nanobodies
- Multivalent Nanobodies
- Fused Nanobodies
- Treatment
- Diagnosis
- Research
- Sino Biological
- GenScript
- Proteintech Group
- Abiocenter
- MerryBio
- Pregene
- Cusabio
- Biocytogen
- Thermo Fisher Scientific
- QVQuality
- HUABIO
- Jackson ImmunoResearch
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe VHH Nanobodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of VHH Nanobodies, with price, sales quantity, revenue, and global market share of VHH Nanobodies from 2020 to 2025.
Chapter 3, the VHH Nanobodies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the VHH Nanobodies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and VHH Nanobodies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of VHH Nanobodies.
Chapter 14 and 15, to describe VHH Nanobodies sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global VHH Nanobodies Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Monovalent Nanobodies
1.3.3 Bivalent Nanobodies
1.3.4 Bispecific Nanobodies
1.3.5 Multivalent Nanobodies
1.3.6 Fused Nanobodies
1.4 Market Analysis by Application
1.4.1 Overview: Global VHH Nanobodies Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Treatment
1.4.3 Diagnosis
1.4.4 Research
1.5 Global VHH Nanobodies Market Size & Forecast
1.5.1 Global VHH Nanobodies Consumption Value (2020 & 2024 & 2031)
1.5.2 Global VHH Nanobodies Sales Quantity (2020-2031)
1.5.3 Global VHH Nanobodies Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Sino Biological
2.1.1 Sino Biological Details
2.1.2 Sino Biological Major Business
2.1.3 Sino Biological VHH Nanobodies Product and Services
2.1.4 Sino Biological VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sino Biological Recent Developments/Updates
2.2 GenScript
2.2.1 GenScript Details
2.2.2 GenScript Major Business
2.2.3 GenScript VHH Nanobodies Product and Services
2.2.4 GenScript VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GenScript Recent Developments/Updates
2.3 Proteintech Group
2.3.1 Proteintech Group Details
2.3.2 Proteintech Group Major Business
2.3.3 Proteintech Group VHH Nanobodies Product and Services
2.3.4 Proteintech Group VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Proteintech Group Recent Developments/Updates
2.4 Abiocenter
2.4.1 Abiocenter Details
2.4.2 Abiocenter Major Business
2.4.3 Abiocenter VHH Nanobodies Product and Services
2.4.4 Abiocenter VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abiocenter Recent Developments/Updates
2.5 MerryBio
2.5.1 MerryBio Details
2.5.2 MerryBio Major Business
2.5.3 MerryBio VHH Nanobodies Product and Services
2.5.4 MerryBio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 MerryBio Recent Developments/Updates
2.6 Pregene
2.6.1 Pregene Details
2.6.2 Pregene Major Business
2.6.3 Pregene VHH Nanobodies Product and Services
2.6.4 Pregene VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Pregene Recent Developments/Updates
2.7 Cusabio
2.7.1 Cusabio Details
2.7.2 Cusabio Major Business
2.7.3 Cusabio VHH Nanobodies Product and Services
2.7.4 Cusabio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cusabio Recent Developments/Updates
2.8 Biocytogen
2.8.1 Biocytogen Details
2.8.2 Biocytogen Major Business
2.8.3 Biocytogen VHH Nanobodies Product and Services
2.8.4 Biocytogen VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biocytogen Recent Developments/Updates
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific VHH Nanobodies Product and Services
2.9.4 Thermo Fisher Scientific VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Thermo Fisher Scientific Recent Developments/Updates
2.10 QVQuality
2.10.1 QVQuality Details
2.10.2 QVQuality Major Business
2.10.3 QVQuality VHH Nanobodies Product and Services
2.10.4 QVQuality VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 QVQuality Recent Developments/Updates
2.11 HUABIO
2.11.1 HUABIO Details
2.11.2 HUABIO Major Business
2.11.3 HUABIO VHH Nanobodies Product and Services
2.11.4 HUABIO VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 HUABIO Recent Developments/Updates
2.12 Jackson ImmunoResearch
2.12.1 Jackson ImmunoResearch Details
2.12.2 Jackson ImmunoResearch Major Business
2.12.3 Jackson ImmunoResearch VHH Nanobodies Product and Services
2.12.4 Jackson ImmunoResearch VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Jackson ImmunoResearch Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VHH NANOBODIES BY MANUFACTURER
3.1 Global VHH Nanobodies Sales Quantity by Manufacturer (2020-2025)
3.2 Global VHH Nanobodies Revenue by Manufacturer (2020-2025)
3.3 Global VHH Nanobodies Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of VHH Nanobodies by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 VHH Nanobodies Manufacturer Market Share in 2024
3.4.3 Top 6 VHH Nanobodies Manufacturer Market Share in 2024
3.5 VHH Nanobodies Market: Overall Company Footprint Analysis
3.5.1 VHH Nanobodies Market: Region Footprint
3.5.2 VHH Nanobodies Market: Company Product Type Footprint
3.5.3 VHH Nanobodies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global VHH Nanobodies Market Size by Region
4.1.1 Global VHH Nanobodies Sales Quantity by Region (2020-2031)
4.1.2 Global VHH Nanobodies Consumption Value by Region (2020-2031)
4.1.3 Global VHH Nanobodies Average Price by Region (2020-2031)
4.2 North America VHH Nanobodies Consumption Value (2020-2031)
4.3 Europe VHH Nanobodies Consumption Value (2020-2031)
4.4 Asia-Pacific VHH Nanobodies Consumption Value (2020-2031)
4.5 South America VHH Nanobodies Consumption Value (2020-2031)
4.6 Middle East & Africa VHH Nanobodies Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global VHH Nanobodies Sales Quantity by Type (2020-2031)
5.2 Global VHH Nanobodies Consumption Value by Type (2020-2031)
5.3 Global VHH Nanobodies Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global VHH Nanobodies Sales Quantity by Application (2020-2031)
6.2 Global VHH Nanobodies Consumption Value by Application (2020-2031)
6.3 Global VHH Nanobodies Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America VHH Nanobodies Sales Quantity by Type (2020-2031)
7.2 North America VHH Nanobodies Sales Quantity by Application (2020-2031)
7.3 North America VHH Nanobodies Market Size by Country
7.3.1 North America VHH Nanobodies Sales Quantity by Country (2020-2031)
7.3.2 North America VHH Nanobodies Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe VHH Nanobodies Sales Quantity by Type (2020-2031)
8.2 Europe VHH Nanobodies Sales Quantity by Application (2020-2031)
8.3 Europe VHH Nanobodies Market Size by Country
8.3.1 Europe VHH Nanobodies Sales Quantity by Country (2020-2031)
8.3.2 Europe VHH Nanobodies Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific VHH Nanobodies Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific VHH Nanobodies Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific VHH Nanobodies Market Size by Region
9.3.1 Asia-Pacific VHH Nanobodies Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific VHH Nanobodies Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America VHH Nanobodies Sales Quantity by Type (2020-2031)
10.2 South America VHH Nanobodies Sales Quantity by Application (2020-2031)
10.3 South America VHH Nanobodies Market Size by Country
10.3.1 South America VHH Nanobodies Sales Quantity by Country (2020-2031)
10.3.2 South America VHH Nanobodies Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa VHH Nanobodies Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa VHH Nanobodies Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa VHH Nanobodies Market Size by Country
11.3.1 Middle East & Africa VHH Nanobodies Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa VHH Nanobodies Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 VHH Nanobodies Market Drivers
12.2 VHH Nanobodies Market Restraints
12.3 VHH Nanobodies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of VHH Nanobodies and Key Manufacturers
13.2 Manufacturing Costs Percentage of VHH Nanobodies
13.3 VHH Nanobodies Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 VHH Nanobodies Typical Distributors
14.3 VHH Nanobodies Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global VHH Nanobodies Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Monovalent Nanobodies
1.3.3 Bivalent Nanobodies
1.3.4 Bispecific Nanobodies
1.3.5 Multivalent Nanobodies
1.3.6 Fused Nanobodies
1.4 Market Analysis by Application
1.4.1 Overview: Global VHH Nanobodies Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Treatment
1.4.3 Diagnosis
1.4.4 Research
1.5 Global VHH Nanobodies Market Size & Forecast
1.5.1 Global VHH Nanobodies Consumption Value (2020 & 2024 & 2031)
1.5.2 Global VHH Nanobodies Sales Quantity (2020-2031)
1.5.3 Global VHH Nanobodies Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Sino Biological
2.1.1 Sino Biological Details
2.1.2 Sino Biological Major Business
2.1.3 Sino Biological VHH Nanobodies Product and Services
2.1.4 Sino Biological VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sino Biological Recent Developments/Updates
2.2 GenScript
2.2.1 GenScript Details
2.2.2 GenScript Major Business
2.2.3 GenScript VHH Nanobodies Product and Services
2.2.4 GenScript VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GenScript Recent Developments/Updates
2.3 Proteintech Group
2.3.1 Proteintech Group Details
2.3.2 Proteintech Group Major Business
2.3.3 Proteintech Group VHH Nanobodies Product and Services
2.3.4 Proteintech Group VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Proteintech Group Recent Developments/Updates
2.4 Abiocenter
2.4.1 Abiocenter Details
2.4.2 Abiocenter Major Business
2.4.3 Abiocenter VHH Nanobodies Product and Services
2.4.4 Abiocenter VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Abiocenter Recent Developments/Updates
2.5 MerryBio
2.5.1 MerryBio Details
2.5.2 MerryBio Major Business
2.5.3 MerryBio VHH Nanobodies Product and Services
2.5.4 MerryBio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 MerryBio Recent Developments/Updates
2.6 Pregene
2.6.1 Pregene Details
2.6.2 Pregene Major Business
2.6.3 Pregene VHH Nanobodies Product and Services
2.6.4 Pregene VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Pregene Recent Developments/Updates
2.7 Cusabio
2.7.1 Cusabio Details
2.7.2 Cusabio Major Business
2.7.3 Cusabio VHH Nanobodies Product and Services
2.7.4 Cusabio VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cusabio Recent Developments/Updates
2.8 Biocytogen
2.8.1 Biocytogen Details
2.8.2 Biocytogen Major Business
2.8.3 Biocytogen VHH Nanobodies Product and Services
2.8.4 Biocytogen VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biocytogen Recent Developments/Updates
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific VHH Nanobodies Product and Services
2.9.4 Thermo Fisher Scientific VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Thermo Fisher Scientific Recent Developments/Updates
2.10 QVQuality
2.10.1 QVQuality Details
2.10.2 QVQuality Major Business
2.10.3 QVQuality VHH Nanobodies Product and Services
2.10.4 QVQuality VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 QVQuality Recent Developments/Updates
2.11 HUABIO
2.11.1 HUABIO Details
2.11.2 HUABIO Major Business
2.11.3 HUABIO VHH Nanobodies Product and Services
2.11.4 HUABIO VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 HUABIO Recent Developments/Updates
2.12 Jackson ImmunoResearch
2.12.1 Jackson ImmunoResearch Details
2.12.2 Jackson ImmunoResearch Major Business
2.12.3 Jackson ImmunoResearch VHH Nanobodies Product and Services
2.12.4 Jackson ImmunoResearch VHH Nanobodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Jackson ImmunoResearch Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VHH NANOBODIES BY MANUFACTURER
3.1 Global VHH Nanobodies Sales Quantity by Manufacturer (2020-2025)
3.2 Global VHH Nanobodies Revenue by Manufacturer (2020-2025)
3.3 Global VHH Nanobodies Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of VHH Nanobodies by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 VHH Nanobodies Manufacturer Market Share in 2024
3.4.3 Top 6 VHH Nanobodies Manufacturer Market Share in 2024
3.5 VHH Nanobodies Market: Overall Company Footprint Analysis
3.5.1 VHH Nanobodies Market: Region Footprint
3.5.2 VHH Nanobodies Market: Company Product Type Footprint
3.5.3 VHH Nanobodies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global VHH Nanobodies Market Size by Region
4.1.1 Global VHH Nanobodies Sales Quantity by Region (2020-2031)
4.1.2 Global VHH Nanobodies Consumption Value by Region (2020-2031)
4.1.3 Global VHH Nanobodies Average Price by Region (2020-2031)
4.2 North America VHH Nanobodies Consumption Value (2020-2031)
4.3 Europe VHH Nanobodies Consumption Value (2020-2031)
4.4 Asia-Pacific VHH Nanobodies Consumption Value (2020-2031)
4.5 South America VHH Nanobodies Consumption Value (2020-2031)
4.6 Middle East & Africa VHH Nanobodies Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global VHH Nanobodies Sales Quantity by Type (2020-2031)
5.2 Global VHH Nanobodies Consumption Value by Type (2020-2031)
5.3 Global VHH Nanobodies Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global VHH Nanobodies Sales Quantity by Application (2020-2031)
6.2 Global VHH Nanobodies Consumption Value by Application (2020-2031)
6.3 Global VHH Nanobodies Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America VHH Nanobodies Sales Quantity by Type (2020-2031)
7.2 North America VHH Nanobodies Sales Quantity by Application (2020-2031)
7.3 North America VHH Nanobodies Market Size by Country
7.3.1 North America VHH Nanobodies Sales Quantity by Country (2020-2031)
7.3.2 North America VHH Nanobodies Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe VHH Nanobodies Sales Quantity by Type (2020-2031)
8.2 Europe VHH Nanobodies Sales Quantity by Application (2020-2031)
8.3 Europe VHH Nanobodies Market Size by Country
8.3.1 Europe VHH Nanobodies Sales Quantity by Country (2020-2031)
8.3.2 Europe VHH Nanobodies Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific VHH Nanobodies Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific VHH Nanobodies Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific VHH Nanobodies Market Size by Region
9.3.1 Asia-Pacific VHH Nanobodies Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific VHH Nanobodies Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America VHH Nanobodies Sales Quantity by Type (2020-2031)
10.2 South America VHH Nanobodies Sales Quantity by Application (2020-2031)
10.3 South America VHH Nanobodies Market Size by Country
10.3.1 South America VHH Nanobodies Sales Quantity by Country (2020-2031)
10.3.2 South America VHH Nanobodies Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa VHH Nanobodies Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa VHH Nanobodies Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa VHH Nanobodies Market Size by Country
11.3.1 Middle East & Africa VHH Nanobodies Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa VHH Nanobodies Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 VHH Nanobodies Market Drivers
12.2 VHH Nanobodies Market Restraints
12.3 VHH Nanobodies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of VHH Nanobodies and Key Manufacturers
13.2 Manufacturing Costs Percentage of VHH Nanobodies
13.3 VHH Nanobodies Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 VHH Nanobodies Typical Distributors
14.3 VHH Nanobodies Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global VHH Nanobodies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global VHH Nanobodies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 4. Sino Biological Major Business
Table 5. Sino Biological VHH Nanobodies Product and Services
Table 6. Sino Biological VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Sino Biological Recent Developments/Updates
Table 8. GenScript Basic Information, Manufacturing Base and Competitors
Table 9. GenScript Major Business
Table 10. GenScript VHH Nanobodies Product and Services
Table 11. GenScript VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GenScript Recent Developments/Updates
Table 13. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 14. Proteintech Group Major Business
Table 15. Proteintech Group VHH Nanobodies Product and Services
Table 16. Proteintech Group VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Proteintech Group Recent Developments/Updates
Table 18. Abiocenter Basic Information, Manufacturing Base and Competitors
Table 19. Abiocenter Major Business
Table 20. Abiocenter VHH Nanobodies Product and Services
Table 21. Abiocenter VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Abiocenter Recent Developments/Updates
Table 23. MerryBio Basic Information, Manufacturing Base and Competitors
Table 24. MerryBio Major Business
Table 25. MerryBio VHH Nanobodies Product and Services
Table 26. MerryBio VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. MerryBio Recent Developments/Updates
Table 28. Pregene Basic Information, Manufacturing Base and Competitors
Table 29. Pregene Major Business
Table 30. Pregene VHH Nanobodies Product and Services
Table 31. Pregene VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Pregene Recent Developments/Updates
Table 33. Cusabio Basic Information, Manufacturing Base and Competitors
Table 34. Cusabio Major Business
Table 35. Cusabio VHH Nanobodies Product and Services
Table 36. Cusabio VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Cusabio Recent Developments/Updates
Table 38. Biocytogen Basic Information, Manufacturing Base and Competitors
Table 39. Biocytogen Major Business
Table 40. Biocytogen VHH Nanobodies Product and Services
Table 41. Biocytogen VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Biocytogen Recent Developments/Updates
Table 43. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Scientific Major Business
Table 45. Thermo Fisher Scientific VHH Nanobodies Product and Services
Table 46. Thermo Fisher Scientific VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Thermo Fisher Scientific Recent Developments/Updates
Table 48. QVQuality Basic Information, Manufacturing Base and Competitors
Table 49. QVQuality Major Business
Table 50. QVQuality VHH Nanobodies Product and Services
Table 51. QVQuality VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. QVQuality Recent Developments/Updates
Table 53. HUABIO Basic Information, Manufacturing Base and Competitors
Table 54. HUABIO Major Business
Table 55. HUABIO VHH Nanobodies Product and Services
Table 56. HUABIO VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. HUABIO Recent Developments/Updates
Table 58. Jackson ImmunoResearch Basic Information, Manufacturing Base and Competitors
Table 59. Jackson ImmunoResearch Major Business
Table 60. Jackson ImmunoResearch VHH Nanobodies Product and Services
Table 61. Jackson ImmunoResearch VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Jackson ImmunoResearch Recent Developments/Updates
Table 63. Global VHH Nanobodies Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global VHH Nanobodies Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global VHH Nanobodies Average Price by Manufacturer (2020-2025) & (K US$/Unit)
Table 66. Market Position of Manufacturers in VHH Nanobodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and VHH Nanobodies Production Site of Key Manufacturer
Table 68. VHH Nanobodies Market: Company Product Type Footprint
Table 69. VHH Nanobodies Market: Company Product Application Footprint
Table 70. VHH Nanobodies New Market Entrants and Barriers to Market Entry
Table 71. VHH Nanobodies Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global VHH Nanobodies Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global VHH Nanobodies Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global VHH Nanobodies Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global VHH Nanobodies Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global VHH Nanobodies Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global VHH Nanobodies Average Price by Region (2020-2025) & (K US$/Unit)
Table 78. Global VHH Nanobodies Average Price by Region (2026-2031) & (K US$/Unit)
Table 79. Global VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global VHH Nanobodies Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global VHH Nanobodies Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global VHH Nanobodies Average Price by Type (2020-2025) & (K US$/Unit)
Table 84. Global VHH Nanobodies Average Price by Type (2026-2031) & (K US$/Unit)
Table 85. Global VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global VHH Nanobodies Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global VHH Nanobodies Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global VHH Nanobodies Average Price by Application (2020-2025) & (K US$/Unit)
Table 90. Global VHH Nanobodies Average Price by Application (2026-2031) & (K US$/Unit)
Table 91. North America VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific VHH Nanobodies Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific VHH Nanobodies Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific VHH Nanobodies Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific VHH Nanobodies Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 131. VHH Nanobodies Raw Material
Table 132. Key Manufacturers of VHH Nanobodies Raw Materials
Table 133. VHH Nanobodies Typical Distributors
Table 134. VHH Nanobodies Typical Customers
Table 1. Global VHH Nanobodies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global VHH Nanobodies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 4. Sino Biological Major Business
Table 5. Sino Biological VHH Nanobodies Product and Services
Table 6. Sino Biological VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Sino Biological Recent Developments/Updates
Table 8. GenScript Basic Information, Manufacturing Base and Competitors
Table 9. GenScript Major Business
Table 10. GenScript VHH Nanobodies Product and Services
Table 11. GenScript VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GenScript Recent Developments/Updates
Table 13. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 14. Proteintech Group Major Business
Table 15. Proteintech Group VHH Nanobodies Product and Services
Table 16. Proteintech Group VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Proteintech Group Recent Developments/Updates
Table 18. Abiocenter Basic Information, Manufacturing Base and Competitors
Table 19. Abiocenter Major Business
Table 20. Abiocenter VHH Nanobodies Product and Services
Table 21. Abiocenter VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Abiocenter Recent Developments/Updates
Table 23. MerryBio Basic Information, Manufacturing Base and Competitors
Table 24. MerryBio Major Business
Table 25. MerryBio VHH Nanobodies Product and Services
Table 26. MerryBio VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. MerryBio Recent Developments/Updates
Table 28. Pregene Basic Information, Manufacturing Base and Competitors
Table 29. Pregene Major Business
Table 30. Pregene VHH Nanobodies Product and Services
Table 31. Pregene VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Pregene Recent Developments/Updates
Table 33. Cusabio Basic Information, Manufacturing Base and Competitors
Table 34. Cusabio Major Business
Table 35. Cusabio VHH Nanobodies Product and Services
Table 36. Cusabio VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Cusabio Recent Developments/Updates
Table 38. Biocytogen Basic Information, Manufacturing Base and Competitors
Table 39. Biocytogen Major Business
Table 40. Biocytogen VHH Nanobodies Product and Services
Table 41. Biocytogen VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Biocytogen Recent Developments/Updates
Table 43. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Scientific Major Business
Table 45. Thermo Fisher Scientific VHH Nanobodies Product and Services
Table 46. Thermo Fisher Scientific VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Thermo Fisher Scientific Recent Developments/Updates
Table 48. QVQuality Basic Information, Manufacturing Base and Competitors
Table 49. QVQuality Major Business
Table 50. QVQuality VHH Nanobodies Product and Services
Table 51. QVQuality VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. QVQuality Recent Developments/Updates
Table 53. HUABIO Basic Information, Manufacturing Base and Competitors
Table 54. HUABIO Major Business
Table 55. HUABIO VHH Nanobodies Product and Services
Table 56. HUABIO VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. HUABIO Recent Developments/Updates
Table 58. Jackson ImmunoResearch Basic Information, Manufacturing Base and Competitors
Table 59. Jackson ImmunoResearch Major Business
Table 60. Jackson ImmunoResearch VHH Nanobodies Product and Services
Table 61. Jackson ImmunoResearch VHH Nanobodies Sales Quantity (K Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Jackson ImmunoResearch Recent Developments/Updates
Table 63. Global VHH Nanobodies Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global VHH Nanobodies Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global VHH Nanobodies Average Price by Manufacturer (2020-2025) & (K US$/Unit)
Table 66. Market Position of Manufacturers in VHH Nanobodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and VHH Nanobodies Production Site of Key Manufacturer
Table 68. VHH Nanobodies Market: Company Product Type Footprint
Table 69. VHH Nanobodies Market: Company Product Application Footprint
Table 70. VHH Nanobodies New Market Entrants and Barriers to Market Entry
Table 71. VHH Nanobodies Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global VHH Nanobodies Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global VHH Nanobodies Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global VHH Nanobodies Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global VHH Nanobodies Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global VHH Nanobodies Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global VHH Nanobodies Average Price by Region (2020-2025) & (K US$/Unit)
Table 78. Global VHH Nanobodies Average Price by Region (2026-2031) & (K US$/Unit)
Table 79. Global VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global VHH Nanobodies Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global VHH Nanobodies Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global VHH Nanobodies Average Price by Type (2020-2025) & (K US$/Unit)
Table 84. Global VHH Nanobodies Average Price by Type (2026-2031) & (K US$/Unit)
Table 85. Global VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global VHH Nanobodies Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global VHH Nanobodies Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global VHH Nanobodies Average Price by Application (2020-2025) & (K US$/Unit)
Table 90. Global VHH Nanobodies Average Price by Application (2026-2031) & (K US$/Unit)
Table 91. North America VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific VHH Nanobodies Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific VHH Nanobodies Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific VHH Nanobodies Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific VHH Nanobodies Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa VHH Nanobodies Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa VHH Nanobodies Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa VHH Nanobodies Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa VHH Nanobodies Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa VHH Nanobodies Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa VHH Nanobodies Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa VHH Nanobodies Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa VHH Nanobodies Consumption Value by Country (2026-2031) & (USD Million)
Table 131. VHH Nanobodies Raw Material
Table 132. Key Manufacturers of VHH Nanobodies Raw Materials
Table 133. VHH Nanobodies Typical Distributors
Table 134. VHH Nanobodies Typical Customers
LIST OF FIGURES
Figure 1. VHH Nanobodies Picture
Figure 2. Global VHH Nanobodies Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global VHH Nanobodies Revenue Market Share by Type in 2024
Figure 4. Monovalent Nanobodies Examples
Figure 5. Bivalent Nanobodies Examples
Figure 6. Bispecific Nanobodies Examples
Figure 7. Multivalent Nanobodies Examples
Figure 8. Fused Nanobodies Examples
Figure 9. Global VHH Nanobodies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global VHH Nanobodies Revenue Market Share by Application in 2024
Figure 11. Treatment Examples
Figure 12. Diagnosis Examples
Figure 13. Research Examples
Figure 14. Global VHH Nanobodies Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global VHH Nanobodies Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global VHH Nanobodies Sales Quantity (2020-2031) & (K Units)
Figure 17. Global VHH Nanobodies Price (2020-2031) & (K US$/Unit)
Figure 18. Global VHH Nanobodies Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global VHH Nanobodies Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of VHH Nanobodies by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 VHH Nanobodies Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 VHH Nanobodies Manufacturer (Revenue) Market Share in 2024
Figure 23. Global VHH Nanobodies Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global VHH Nanobodies Consumption Value Market Share by Region (2020-2031)
Figure 25. North America VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 28. South America VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 30. Global VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global VHH Nanobodies Consumption Value Market Share by Type (2020-2031)
Figure 32. Global VHH Nanobodies Average Price by Type (2020-2031) & (K US$/Unit)
Figure 33. Global VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global VHH Nanobodies Revenue Market Share by Application (2020-2031)
Figure 35. Global VHH Nanobodies Average Price by Application (2020-2031) & (K US$/Unit)
Figure 36. North America VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 40. United States VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 48. France VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific VHH Nanobodies Consumption Value Market Share by Region (2020-2031)
Figure 56. China VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 59. India VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 62. South America VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 76. VHH Nanobodies Market Drivers
Figure 77. VHH Nanobodies Market Restraints
Figure 78. VHH Nanobodies Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of VHH Nanobodies in 2024
Figure 81. Manufacturing Process Analysis of VHH Nanobodies
Figure 82. VHH Nanobodies Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. VHH Nanobodies Picture
Figure 2. Global VHH Nanobodies Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global VHH Nanobodies Revenue Market Share by Type in 2024
Figure 4. Monovalent Nanobodies Examples
Figure 5. Bivalent Nanobodies Examples
Figure 6. Bispecific Nanobodies Examples
Figure 7. Multivalent Nanobodies Examples
Figure 8. Fused Nanobodies Examples
Figure 9. Global VHH Nanobodies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global VHH Nanobodies Revenue Market Share by Application in 2024
Figure 11. Treatment Examples
Figure 12. Diagnosis Examples
Figure 13. Research Examples
Figure 14. Global VHH Nanobodies Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global VHH Nanobodies Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global VHH Nanobodies Sales Quantity (2020-2031) & (K Units)
Figure 17. Global VHH Nanobodies Price (2020-2031) & (K US$/Unit)
Figure 18. Global VHH Nanobodies Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global VHH Nanobodies Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of VHH Nanobodies by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 VHH Nanobodies Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 VHH Nanobodies Manufacturer (Revenue) Market Share in 2024
Figure 23. Global VHH Nanobodies Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global VHH Nanobodies Consumption Value Market Share by Region (2020-2031)
Figure 25. North America VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 28. South America VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 30. Global VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global VHH Nanobodies Consumption Value Market Share by Type (2020-2031)
Figure 32. Global VHH Nanobodies Average Price by Type (2020-2031) & (K US$/Unit)
Figure 33. Global VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global VHH Nanobodies Revenue Market Share by Application (2020-2031)
Figure 35. Global VHH Nanobodies Average Price by Application (2020-2031) & (K US$/Unit)
Figure 36. North America VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 40. United States VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 48. France VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific VHH Nanobodies Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific VHH Nanobodies Consumption Value Market Share by Region (2020-2031)
Figure 56. China VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 59. India VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 62. South America VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa VHH Nanobodies Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa VHH Nanobodies Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa VHH Nanobodies Consumption Value (2020-2031) & (USD Million)
Figure 76. VHH Nanobodies Market Drivers
Figure 77. VHH Nanobodies Market Restraints
Figure 78. VHH Nanobodies Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of VHH Nanobodies in 2024
Figure 81. Manufacturing Process Analysis of VHH Nanobodies
Figure 82. VHH Nanobodies Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
